Skip to main content

Abbott and DexCom settle glucose monitor patent disputes

By MSN  
   December 27, 2024

Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

Full story


Get the latest on healthcare leadership in your inbox.